Algenex and FATRO announce positive CVMP opinion for CrisBio-based vaccine for Rabbit Viral Haemorrhagic Disease
21. Juni 2021 07:00 ET
|
Algenex SL
PRESS RELEASE Algenex and FATRO announce positive CVMP opinion for CrisBio-based vaccine for Rabbit Viral Haemorrhagic Disease Madrid (Spain) and Bologna (Italy), June 21, 2021 – Algenex SL, a...
Algenex advances insect-based vaccine production technology in human health
05. Mai 2020 02:00 ET
|
Algenex SL
PRESS RELEASE Algenex advances insect-based vaccine production technology in human health CrisBio® offers efficient, economic and rapid response tool in pandemics. Madrid, May 5, 2020.- Algenex SL...